tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market
Holding ABOS?
Track your performance easily

Acumen Pharmaceuticals (ABOS) Financial Statements

409 Followers

Acumen Pharmaceuticals Financial Overview

Acumen Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.37; its P/E ratio is -1.69; Acumen Pharmaceuticals is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ 5.00K-
Gross Profit---$ 5.00K-
EBIT$ -29.77M$ -20.54M$ -13.87M$ -9.14M$ -16.04M
EBITDA$ -29.72M$ -18.73M$ -13.83M$ -9.10M$ -16.00M
Net Income Common Stockholders$ -29.77M$ -20.54M$ -14.87M$ -16.50M$ -12.96M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 200.34M$ 260.47M$ 252.51M$ 243.52M$ 215.43M
Total Assets$ 266.98M$ 288.91M$ 300.97M$ 310.13M$ 286.37M
Total Debt$ 29.99M$ 29.72M$ 30.58M$ 31.05M$ 2.00K
Net Debt$ -170.35M$ -230.75M$ -221.93M$ -212.47M$ -215.43M
Total Liabilities$ 49.77M$ 44.97M$ 38.93M$ 43.15M$ 6.10M
Stockholders Equity$ 217.20M$ 243.95M$ 262.00M$ 266.97M$ 280.27M
Cash Flow-
Free Cash Flow$ -24.60M$ -16.55M$ -17.87M$ -8.33M$ -12.91M
Operating Cash Flow$ -24.60M$ -16.55M$ -17.86M$ -8.31M$ -12.90M
Investing Cash Flow$ -10.13M$ 37.70M$ -9.20M$ -48.81M$ -92.00M
Financing Cash Flow$ -42.00K$ -128.00K$ 7.11M$ 29.13M$ 122.76M
Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History

Acumen Pharmaceuticals Debt to Assets

Acumen Pharmaceuticals Cash Flow

Acumen Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis